Separately, Russia's Interfax news agency cited "an informed source" as saying the vaccine would be registered from August 10-12 and be administered from August 15 onwards.
Russian Federation is racing to be the first nation in the world to approve a COVID vaccine by mid-August. In just less than two weeks the nation plans on approving itscoronavirus vaccine despite lingering concerns regarding its effectiveness and safety, reports suggest. In parallel to the phase-3 trials which are scheduled to start from 4th August onward, the frontline health workers in Russian Federation will receive Gamaleya Institute's COVID-19 vaccine once it gets the due approval from authorities, CNN reported.
"Americans were surprised when they heard Sputnik's beeping", Dmitriev said. It's the same with this vaccine.
That has not stopped Russian officials from heralding their claims, telling CNN they are aiming for August 10 or earlier, and frontline workers will get the first doses.
However, Russia is yet to release the scientific data on its coronavirus vaccine trials, hence, questions remain about the safety and efficacy of the vaccine, said the report.
"Now we will see which categories will get the vaccine first".
"Critics say the country's push for a vaccine comes amid political pressure from the Kremlin, which is keen to portray Russian Federation as a global scientific force", notes the report.
A state research facility in Moscow - the Gamaleya Institute - completed early human trials of the adenovirus-based vaccine this month and expects to begin large-scale trials in August. That phase is expected to be finished by August 3, while the third phase is run in conjunction with the vaccination of medical workers.
The vaccine has been quick to develop because it is a modified version of one already created to fight against other diseases. That's the approach being taken in many other countries and by other companies, claimed the Russian scientists. Russia's defense ministry says that Russian soldiers served as volunteers in human trials.
Ms Golikova's remarks follow a CNN interview with the head of Russia's sovereign welfare fund that bankrolls research and development for the coronavirus vaccine at the Gamalei Institute of Epidemiology and Microbiology.